Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Omega Diagnostics ( (GB:CNSL) ) just unveiled an update.
Cantor Fitzgerald Europe has increased its voting rights in Cambridge Nutritional Sciences PLC to 6.1004%, up from a previous 5.2074%. This acquisition of financial instruments signifies a strategic move that could influence the company’s governance and decision-making processes, potentially impacting its market positioning and stakeholder interests.
More about Omega Diagnostics
Cambridge Nutritional Sciences PLC operates in the UK and focuses on nutritional science, offering products and services related to health diagnostics and nutritional testing.
YTD Price Performance: 14.55%
Average Trading Volume: 376,571
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £7.73M
Find detailed analytics on CNSL stock on TipRanks’ Stock Analysis page.